Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK3858279 crossover evoked pain study in healthy volunteers
NL-OMON55004Completed
- Sponsor
- GSK
- Start
- Oct 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Randomised, double-blind trial of GSK3858279 in chronic pain, sponsored by GSK. Primary endpoints: UVB heat pain detection threshold, Cold pressor time to intolerable pain threshold and 1 more. Started Oct 2019; status: completed.
02
Drugs
GSK3858279
03
Conditions
chronic pain
Beyond the preview
Go deeper on NL-OMON55004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55004.